Paul Harkin

Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004.

Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004.

Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004.

Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004.